Industry Experts - Market Research

Automation, Rapid Diagnostics, and Rising Sepsis Burden Drive Global Blood Culture Test Market to US$14 Billion by 2032

Wednesday Nov 26, 2025

Industry Experts, Inc. has unveiled its latest market research publication, "Blood Culture Test - A Global Market Overview," estimating that global revenues will rise from US$7 billion in 2025 to US$14 billion by 2032, registering a CAGR of 10.5% during 2025-2032. Growth is powered by rising cases of bloodstream infections and sepsis, increased antimicrobial resistance, expanding surgical and ICU admissions, and rapid adoption of automated and molecular diagnostic technologies that improve speed, accuracy, and clinical outcomes.

Rising sepsis-related mortality, an aging and immunocompromised population, and increasing hospital-acquired infections have strengthened clinical emphasis on early pathogen detection and targeted therapy. Advancements in continuous-monitoring culture systems, PCR-based assays, and MALDI-TOF MS proteomics are transforming diagnostic workflows, reducing turnaround times, and supporting antibiotic stewardship. Hospitals are implementing automated blood culture platforms to comply with global sepsis management guidelines, while emerging markets are accelerating investments in lab modernization, infection control initiatives, and rapid diagnostics adoption. Although high instrument costs and operational constraints in developing regions remain challenges, continued R&D investment, AI-assisted interpretation tools, and regulatory approvals for faster and more sensitive systems are driving sustained market expansion.

North America dominates the global blood culture test market with a 39.9% share in 2025, supported by advanced healthcare infrastructure, strong R&D spending, high sepsis prevalence, and robust adoption of automated systems from leading companies such as BD, bioMerieux, and Thermo Fisher. Favorable reimbursement, stringent infection control regulations, and federally funded antimicrobial resistance programs further strengthen regional leadership. In contrast, Asia-Pacific is projected to grow the fastest at an 11.5% CAGR through 2032, fueled by rising infectious disease burden, modernization of diagnostic laboratories, expanded automation across China and India, supportive government programs, and increasing awareness of early sepsis detection.

By product, Consumables lead the market with a 57% share in 2025, driven by essential single-use culture bottles, media, and reagents required for every test and reinforced by updated sepsis protocols. Instruments are set to expand the fastest at an 11.3% CAGR, propelled by rising automation and demand for high-throughput, real-time detection platforms. By method, Conventional/Manual Methods retain a 59% share, particularly in cost-sensitive regions, while Automated Methods grow the fastest at 11.2% CAGR due to improved accuracy, reduced contamination risk, and integration with molecular tools. By technology, Culture-based testing dominates with a 64% share, maintaining its status as the gold standard for viable pathogen detection and antimicrobial susceptibility testing. Molecular technology grows the fastest at 11.6% CAGR, driven by rapid pathogen and resistance gene identification. By application, Bacteremia leads with over 70% share, while Fungemia expands the fastest at more than 11% CAGR. By end user, Hospital Laboratories hold a 55% share, with Reference Laboratories growing the fastest at 11.8% CAGR, supported by outsourcing trends and high-volume, complex testing capabilities.

The report segments the global Blood Culture Test market by Product (Consumables, Instruments, Software & Services), Method (Conventional/Manual Methods, Automated Methods), Technology (Culture-based, Molecular, Proteomics-based), Application (Bacteremia, Fungemia, Mycobacterial Detection), and End User (Hospital Laboratories, Reference Laboratories, Academic & Research, Other End Users). Geographic coverage spans North America, Europe, Asia-Pacific, South America, and Rest of World, with profiles of 11+ companies, including Abbott, BD, bioMerieux, Bruker, Danaher, DiaSorin, Roche, Siemens Healthineers, Terumo, and Thermo Fisher Scientific.

For sample pages or purchase options, contact +1-320-497-3787 or visit Blood Culture Test Market.

About Industry Experts, Inc.

Industry Experts, Inc. ranks among the leading global market research providers. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to corporate strategists, analysts, researchers, and startups seeking unbiased current and future market data. For more information, contact +1-320-497-3787 or visit https://industry-experts.com.